People living with MS in England, Wales and Northern Ireland who are currently receiving the drug ocrelizumab via an infusion can now be offered an injection that takes just ten minutes.
Ocrelizumab is a disease modifying therapy (DMT) for active relapsing MS or early primary progressive MS. It can be taken as an intravenous infusion and after starting with two infusions close together, you can take ocrelizumab just every six months. Now you can also take it as an injection once every six months.
This method will expand the choices available to many MS patients and will mean more people can receive this treatment in a way that suits them.
You can find out more on the MS Society’s Ocrelizumab information page
There is also more information on the BBC website.